The global Cholesterol Lowering Drugs Market is projected to reach approximately US$ 37.7 billion by 2027, expanding at a compound annual growth rate (CAGR) of around 3% from 2019 to 2027. Cholesterol lowering drugs, including statins, PCSK9 inhibitors, and bile acid sequestrants, manage hypercholesterolemia to reduce cardiovascular disease risk. The market's growth is driven by increasing...